Chinese health biotech and the billion-patient market

被引：62

作者：

Frew, Sarah E. ^{[1
,2
]}

Sammut, Stephen M. ^{[3
,4
]}

Shore, Alysha F. ^{[1
,2
]}

Ramjist, Joshua K. ^{[1
,2
]}

Al-Bader, Sara ^{[1
,2
]}

Rezaie, Rahim ^{[1
,2
]}

Daar, Abdallah S. ^{[1
,2
]}

Singer, Peter A. ^{[1
,2
]}

机构：

[1] Univ Hlth Network, McLaughlin Rotman Ctr Global Hlth, Toronto, ON M5G 1L7, Canada

[2] Univ Toronto, MaRS Ctr, Toronto, ON M5G 1L7, Canada

[3] Univ Penn, Philadelphia, PA 19104 USA

[4] Burrill & Co, Embarcadero Ctr 1, San Francisco, CA 94111 USA

来源：

NATURE BIOTECHNOLOGY | 2008年 / 26卷 / 01期

关键词：

D O I：

10.1038/nbt0108-37

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Chinese government support and 'sea turtles' are spurring the sector, but investors lack exits.

引用

页码：37 / 53

页数：17

共 19 条

[1]

[Anonymous], NY TIMES

[2]

BIAN L, 2007, CHINA DAILY 0917, P14

[3] Immunization coverage and its determinants in children aged 12-23 months in Gansu, China [J].

Cui, Fu-Qiang ;

Gofin, Rosa .

VACCINE, 2007, 25 (04) :664-671

[4]

*EC INT UN LIM, 2007, COUNTR PROF 2007 CHI

[5] India's health biotech sector at a crossroads [J].

Frew, Sarah E. ;

Rezaie, Rahim ;

Sammut, Stephen M. ;

Ray, Monali ;

Daar, Abdallah S. ;

Singer, Peter A. .

NATURE BIOTECHNOLOGY, 2007, 25 (04) :403-417

[6]

Hu Xianwen, 2006, Biotechnology Journal, V1, P1215, DOI 10.1002/biot.200600083

[7]

HU YY, 2004, CHINA DAILY BEI 1222, P9

[8] China syndrome - a regulatory framework in meltdown? [J].

Jia, Hepeng .

NATURE BIOTECHNOLOGY, 2007, 25 (08) :834-836

[9] Chinese biotech hamstrung by production issues [J].

Jia, Hepeng .

NATURE BIOTECHNOLOGY, 2007, 25 (02) :147-148

[10]

LEE E, 2006, TONGJITANG SEEKS FDA

← 1 2 →